Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

Adverse events associated with unblinded, but not with blinded

Rosuvastatin in the Primary Prevention of Cardiovascular Disease

Statins for Graves' orbitopathy: a new tool for prevention and

Graves Disease: Practice Essentials, Pathophysiology, Epidemiology

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

Full article: How can we prevent disease relapse in Graves

Effect of dapagliflozin on the rate of decline in kidney function

Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO